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Synucleins are a family of homologous proteins principally known
for their involvement in neurodegeneration. γ-Synuclein is highly
expressed in human white adipose tissue and increased in obesity.
Here we show that γ-synuclein is nutritionally regulated in white
adipose tissue whereas its loss partially protects mice from high-fat
diet (HFD)–induced obesity and ameliorates some of the associated
metabolic complications. Comparedwith HFD-fedWTmice, HFD-fed
γ-synuclein–null mutant mice display increased lipolysis, lipid oxida-
tion, and energy expenditure, and reduced adipocyte hypertrophy.
Knockdown of γ-synuclein in adipocytes causes redistribution of the
key lipolytic enzyme ATGL to lipid droplets and increases lipolysis.
γ-Synuclein–deﬁcient adipocytes also contain fewer SNARE com-
plexes of a type involved in lipid droplet fusion. We hypothesize
that γ-synuclein may deliver SNAP-23 to the SNARE complexes un-
der lipogenic conditions. Via these independent but complementary
roles, γ-synuclein may coordinately modulate lipid storage by inﬂu-
encing lipolysis and lipid droplet formation. Our data reveal γ-syn-
uclein as a regulator of lipid handling in adipocytes, the function of
which is particularly important in conditions of nutrient excess.
Understanding the link between increased adiposity and thedevelopment of metabolic disease may reveal novel thera-
peutic targets to counter the rising pandemic of obesity. Inhib-
iting adipose tissue expansion alone is likely to worsen metabolic
outcome, as evidenced by human syndromes of lipodystrophy,
whereby inappropriately decreased adipose mass causes severe
metabolic disorders (1). Indeed, adipose tissue dysfunction and/
or exceeded adipose storage capacity may underlie ectopic lipid
accumulation and lipotoxicity in obesity (2). Therefore, a major
challenge is to identify pathways via which adiposity can be re-
duced without concomitant increases in circulating lipids and
attendant metabolic disease. Achieving this goal requires a better
understanding of the molecular mechanisms that regulate lipid
metabolism and storage in adipocytes, particularly in times of
energy surplus.
γ-Synuclein belongs to the synuclein family of proteins, whose
founder member α-synuclein is best known for its links with
neurodegenerative diseases, most notably Parkinson disease (3).
To date, no clear cellular role is attributed to γ-synuclein, and
ablation of γ-synuclein causes only minor changes in the nervous
system (4–7). Recently, we and others have reported high levels
of γ-synuclein expression in adipose tissue of humans and other
mammals (8, 9). Moreover, expression of γ-synuclein is increased
in the adipose tissue of obese humans and decreased during
caloric restriction (8).
Here we demonstrate that γ-synuclein–null mice display sig-
niﬁcantly reduced adiposity and fewer metabolic derangements
compared with WT mice following high-fat feeding. This appears
to result from increased adipocyte lipolysis coupled to enhanced
whole-body lipid oxidation and energy expenditure. At a molec-
ular level, we identify dual roles for γ-synuclein independently
regulating lipid droplet fusion and adipocyte lipolysis to co-
ordinately regulate triglyceride (TG) storage in adipocytes. To-
gether, our observations reveal that γ-synuclein is a regulator of
lipid metabolism and, hence, a potential therapeutic target for
treatment of obesity and associated metabolic diseases.
Results
γ-Synuclein Expression Is Nutritionally Regulated in Adipocytes.
γ-Synuclein is abundantly expressed in adipose tissue (8, 9) (Fig.
S1). Western blotting of fractionated white adipose tissue (WAT)
demonstrated that γ-synuclein was expressed in the mature adi-
pocyte but not the stromal cell fraction (Fig. 1A). When adipo-
cytes were subjected to subcellular fractionation, γ-synuclein was
recovered in the infranatant, containing cytosol and membranes.
No γ-synuclein was detected in the fraction containing lipid
droplet-associated proteins in the presence or absence of lipo-
lytic stimulation, which was sufﬁcient to induce the translocation
of hormone-sensitive lipase (HSL; Fig. 1B). Immunostaining of
adipocytes differentiated from MEFs in vitro also revealed dif-
fuse, partly punctuate cytoplasmic staining, and did not suggest
an association of γ-synuclein with lipid droplets (Fig. 1C).
Consistent with previous observations in patients with obesity
(8), γ-synuclein mRNA expression was dramatically increased in
the epididymal and s.c.WAT ofmice fed a high-fat diet (HFD) for
11 wk (Fig. 1D) and gradually decreased after mice fed an HFD
for 10 d were switched to a low-fat diet (LFD) or fasted (Fig. 1E).
Parallel changes in γ-synuclein protein levels were observed in
epididymal WAT following dietary manipulation (Fig. 1F).
γ-Synuclein–Null Mice Are Resistant to Diet-Induced Obesity. The
nutritional regulation of γ-synuclein expression in adipose tissue
led us to investigate whether it could play a role in the de-
velopment of obesity. WT and γ-synuclein−/− mice (9 wk old)
were fed an LFD or HFD for a period of 11 wk. LFD-fed WT
and γ-synuclein−/− mice showed no differences in weight gain. In
contrast, during HFD-feeding, γ-synuclein−/− mice gained sub-
stantially less weight than their WT counterparts (Fig. 2A).
Quantitative MRI analysis of body fat volume during the study
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revealed signiﬁcantly reduced WAT accumulation in HFD-fed
γ-synuclein−/− mice compared with WT mice (Fig. 2B and Fig.
S2A). This reduction was conﬁrmed postmortem by determining
the mass of dissected epididymal, s.c., and retroperitoneal de-
pots, as well as fat pad mass to body mass ratios for all three
depots (Fig. 2C, Fig. S2 B and C, and Table S1).
Observed differences in WAT accumulation between HFD-
fed WT and γ-synuclein−/− mice were not explained by altered
food intake (Fig. S2D) or absorption of lipids from the diet (Fig.
S2E). White adipocytes were of similar size in LFD-fed mice of
both genotypes; upon HFD feeding, the average adipocyte size
increased by ∼4.5 fold in s.c. WAT of WT mice but only ∼2.4 fold
in γ-synuclein−/− mice (Fig. 2 D and E). To investigate whether
the lack of γ-synuclein affected adipocyte size in a cell-autono-
mous manner, we injected lentiviruses containing a bicistronic
construct encoding GFP and γ-synuclein locally into femoral s.c.
fat pads of γ-synuclein−/− mice before the 11-wk HFD feeding
protocol. This allowed us to speciﬁcally identify adipocytes
reexpressing γ-synuclein by GFP staining (Fig. S2G). Following
11 wk on an HFD, we observed a statistically signiﬁcant increase
in size of adipocytes transduced with γ-synuclein–expressing len-
tivirus when compared with adjacent nontransduced cells or cells
transduced with a control lentivirus expressing only GFP in the
contralateral WAT depot of the same animal (Fig. 2F). Overall,
these data strongly suggest that regulation of γ-synuclein within
fat cells speciﬁcally and cell-autonomously affects adipocyte size
Fig. 1. Expression of γ-synuclein in murine WAT. (A)
Western blot analysis of γ-synuclein expression in the
total cell lysates of stromal–vascular (SV) and mature
adipocyte fractions from epididymal WAT of WTmice.
A lysate of epididymal WAT from a γ-synuclein−/−
mouse(γ−/−WAT)was includedasacontrol.GAPDHwas
used as a loading control. (B) Subcellular localization of
γ-synuclein in mature white adipocytes isolated from
epididymalWAT ofWTmice with 30min incubation in
the presence or absence of 10 μM isoproterenol. Pro-
teins in the pellet (marked “P”), supernatant (SN), and
fat cake (FC) fractions were Western-blotted by using
antibodies to γ-synuclein and protein markers for each
fraction. (C) Immunoﬂuorescent staining of MEFs dif-
ferentiated into adipocytes with SK23 antibodies (29)
against γ-synuclein (red) and counterstained with
the neutral lipid stain Bodipy 493/505 (green). (Scale
bar: 20 μm.) (D) Quantitative RT-PCR analysis of γ-syn-
uclein mRNA expression in epididymal (ED; n = 8) and
s.c. (n = 4) WAT of WT mice fed an LFD or HFD for
11wk. Results are shownasmean±SEMof fold change
compared with LFD-fed mice. (E) Quantitative RT-PCR
analysis of γ-synuclein mRNA expression in epididymal
ands.c.WATofmice fedanHFDfor10dandthengiven
LFD for 36 h or 1 wk, fasted for 36 h, or maintained on
HFD. Results are shown as mean ± SEM fold change
compared with HFD-fed controls (n = 3–5). (F) Western
blot analysis of γ-synuclein expression in epididymal
WAT of the same mice used in D and E. GAPDH was
used as a loading control. (InDandE, *P< 0.05, **P<
0.01, and ***P < 0.001, Mann–Whitney U test.)
Fig. 2. Effect of γ-synuclein deﬁciency on WAT of
mice challenged with HFD. (A) Body weight changes
of WT (+/+) and γ-synuclein−/−mice (−/−) fed an LFD or
HFD for 11 wk (n = 12–15). (B) MRI scans (fat-only
images, fat shown in white) of WT and γ-synuclein−/−
mice at the beginning (9 wk), middle (15 wk), and
end (20 wk) of LFD or HFD feeding. (C) Total epi-
didymal (ED) WAT mass to body mass ratios of WT
and γ-synuclein−/− mice fed an LFD or HFD for 11 wk
(n = 12–14). (D) H&E-stained sections through s.c.
WAT taken from WT and γ-synuclein−/− mice fed an
LFD or HFD for 11 wk. (Scale bar: 50 μm.) (E) Average
white adipocyte area for these groups was quanti-
ﬁed by using ImageJ (n = 3 animals/12 sections, per
group). (F) Average adipocyte area was measured on
GFP antibody-stained sections of s.c. WAT of γ-syn-
uclein−/− mice that received local injection of γ-syn-
uclein–expressing lentivirus (γ) or control GFP-only–
expressing lentivirus (GFP) into s.c. WAT followed by
feeding HFD for 11 wk (n = 3 animals/12 sections per
group, minimum of 600 adipocytes). Bar charts rep-
resent mean ± SEM (*P < 0.05, **P < 0.01, Mann–
Whitney U test).
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in vivo. We observed no difference in the induction of several
markers of adipogenesis in γ-synuclein–null and WT MEFs in-
duced to differentiate in culture (Fig. S2 H–J), suggesting that the
effects observed in vivo do not reﬂect decreased adipogenic ca-
pacity of γ-synuclein precursor cells.
Loss of γ-Synuclein Ameliorates HFD-Induced Hyperinsulinemia
and Hepatosteatosis and Increases Lipid Oxidation and Energy
Expenditure. Restricting adiposity in the setting of nutrient ex-
cess may lead to an increased circulating lipids and ectopic lipid
accumulation in nonadipose tissues, causing or exacerbating in-
sulin resistance and metabolic disorders (1, 2). Whereas HFD
feeding resulted in an approximately twofold increase in hepatic
and plasma triacylglycerol (TAG) levels in WT mice, no such
increases were observed in γ-synuclein−/− mice despite their re-
duced adiposity (Fig. 3 A and B). Histological examination of
H&E-stained sections revealed that the absence of γ-synuclein
protected the liver from the development of the extensive hep-
atosteatosis observed in HFD-fed WT mice (Fig. 3C). Similarly,
whereas HFD feeding dramatically altered the morphology of
brown adipose tissue (BAT) in WT mice with the appearance of
much larger lipid droplets, this was signiﬁcantly attenuated in
γ-synuclein−/− mice (Fig. 3C). γ-Synuclein−/− mice also appeared
protected against the signiﬁcant increase in fasting plasma in-
sulin levels observed in WT mice following HFD feeding (Fig.
3D). Commensurate with their altered adiposity, plasma leptin
levels were also lower in γ-synuclein−/− vs. WT mice fed an HFD
(Fig. 3E). The absence of γ-synuclein had no effect on the levels
of plasma free fatty acids, ketone bodies, or adiponectin on LFD
or HFD (Table S2). i.p. glucose and insulin tolerance tests also
revealed no signiﬁcant differences between γ-synuclein−/− and
WT mice in the area under the curve (Table S2), although glu-
cose levels in both tests were lower in γ-synuclein–deﬁcient mice
at all time points tested (Fig. S3). Taken together, these data
suggest that the reduced adiposity observed in γ-synuclein–de-
ﬁcient mice is accompanied by a partly improved, rather than
worsened, metabolic proﬁle compared with WT mice when both
are fed an HFD. This is a result of signiﬁcantly improved aspects
of lipid metabolism, and any effects on glucose metabolism are
more modest and may be secondary.
Given that the observed decreases in adiposity and ectopic
lipid storage are not attributed to decreased caloric intake, we
next examined substrate utilization and energy expenditure in
γ-synuclein−/− mice. Analysis of HFD-fed mice by indirect cal-
orimetry using a Comprehensive Lab Animal Monitoring System
(CLAMS) revealed that γ-synuclein−/− mice had a signiﬁcantly
lower respiratory exchange ratio (RER), consistent with in-
creased lipid oxidation and reduced carbohydrate oxidation (Fig.
3F and Fig. S4 A and B). HFD-fed γ-synuclein−/− mice also
exhibited increased energy expenditure during the light cycles
(Fig. 3G). This was despite lower levels of physical activity
(Fig. S4C).
Analysis of the expression of mRNA encoding proteins in-
volved in the regulation of lipid oxidation (PPARγ coactivator
1α, uncoupling protein 3, PPARα, peroxisomal acyl-CoA oxidase
1, acyl-CoA synthetase long-chain family member 1, and carni-
tine palmitoyltransferase 1) revealed that these were increased in
BAT but not in WAT of HFD-fed γ-synuclein−/− mice compared
with corresponding control mice (Fig. S5). This strongly implies
that the increased lipid oxidation observed in the γ-synuclein−/−
mice at least partly occurs in the BAT and that the associated
energy is likely to be dissipated as heat.
Loss of γ-Synuclein Increases Lipolysis in Vivo and in Vitro. We next
investigated whether reduced lipid storage and increased lipid
utilization in γ-synuclein−/− mice fed an HFD could be associated
with altered adipocyte lipolysis. Glycerol release was approxi-
mately threefold higher in epididymal adipocytes isolated from
HFD-fed γ-synuclein−/− mice compared with adipocytes from
HFD-fed WT mice under basal conditions. Moreover, although
isoproterenol dramatically stimulated glycerol release in adipo-
cytes of both genotypes, this remained signiﬁcantly higher in adi-
pocytes from γ-synuclein−/− mice (Fig. 4A). Conversely, lentiviral
reexpression of γ-synuclein reduced the rate of basal lipolysis in
MEFs derived from γ-synuclein−/− mice and differentiated into
adipocyte-like cells (Fig. 4B). We did not observe altered expres-
sion of perilipin A or HSL in the WAT of γ-synuclein−/− mice fed
HFD compared with HFD-fed WT mice. Moreover, we did not
observe increased phosphorylation of HSL at serine 563 or serine
660, although levels of ATGL were increased in the WAT of
HFD-fed γ-synuclein−/− mice (Fig. 4C and Table S3).
To further investigate the mechanism via which γ-synuclein
loss might increase lipolysis, we used siRNA to knock down
γ-synuclein in mature 3T3-L1 adipocytes. This led to an ∼90%
decrease in γ-synuclein mRNA levels with no effect on any ad-
ipocyte marker genes tested (Fig. S6A). Levels of γ-synuclein
protein were undetectable in these cells, and expression of the
adipocyte marker aP2 was unchanged (Fig. 5A). Consistent with
the effects of gene KO in vivo, γ-synuclein knockdown signiﬁ-
cantly increased basal and isoproterenol-stimulated rates of li-
polysis (Fig. 5A). Also consistent with the effects of altering
γ-synuclein levels in adipocytes in vivo, lipid droplet size was
Fig. 3. Effect of γ-synuclein deﬁciency on non-WAT
lipid accumulation, hormonal status, and metabo-
lism. (A and B) Levels of TAG in liver (n = 5–8) and
plasma (n = 5–7) of WT (+/+) and γ-synuclein−/− mice
(−/−) fed an LFD or HFD for 11 wk. (C) H&E-stained
sections through BAT and liver of WT and γ-synu-
clein−/− mice fed an LFD or HFD for 11 wk. (Scale
bar: 50 μm.) (D and E) Levels of insulin and leptin in
plasma of WT and γ-synuclein−/− mice fed an LFD or
HFD for 11 wk (n = 11–14). (F) RER calculated by
indirect calorimetry using CLAMS over a period of
72 h in WT (+/+) and γ-synuclein−/− (−/−) mice fed an
HFD for 8 wk at the time of the trial (n = 8 per
genotype). (G) Energy expenditure by these animals
over the same time period. Black bars indicate
periods of dark cycles. Individual values represent
mean ± SEM (*P < 0.05, **P < 0.01, Mann–Whitney
U test).
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signiﬁcantly reduced in 3T3-L1 adipocytes in which γ-synuclein
had been knocked down (Fig. 5B).
Despite increased ATGL protein expression in the adipose
tissue of γ-synuclein−/− mice, we did not detect a consistent al-
teration in ATGL expression following knockdown of γ-synu-
clein in 3T3-L1 adipocytes, suggesting that this may represent
a secondary effect. However, γ-synuclein knockdown did result
in a dramatic redistribution of ATGL in 3T3-L1 adipocytes, re-
sulting in a distinctive patterning of ATGL staining around lipid
droplets in the basal state (Fig. 5C). This pattern was similar to
that seen when cells transfected with control siRNA are stimu-
lated with isoproterenol (Fig. 5C). In vitro pull-down assays in-
dicated that γ-synuclein and ATGL are capable of interacting
(Fig. S6B). However, we did not observe interaction of γ-synu-
clein with perilipin A or CGI-58 in the same assay (Fig. S6C).
These observations suggest that γ-synuclein could be involved in
sequestering ATGL away from the lipid droplets in the basal
state. Together, our data strongly argue that the altered lipolysis
and decreased adipocyte size observed in the γ-synuclein−/− mice
results from a cell-autonomous effect of γ-synuclein loss in adi-
pocytes whereby the pool of ATGL targeted to lipid droplets is
increased, promoting its involvement in basal and hormonally
stimulated TG hydrolysis.
γ-Synuclein Promotes Assembly of SNARE Complexes in WAT and
Cultured Cells. α- and γ-Synuclein are closely related proteins,
with potential functional redundancy (5, 10). In neuronal syn-
apses, α-synuclein is involved in regulation of synaptic vesicle
fusion with the cell membrane by promoting the assembly of
SNARE complexes (11). In adipocytes, SNARE complexes have
been implicated in lipid droplet formation and growth by fusion
between neutral TAG packaged within amphipathic lipoproteins
and the lipid droplet phospholipid monolayer (12–15). To de-
termine whether γ-synuclein may regulate the efﬁciency of this
fusion mechanism, we quantiﬁed the assembled SNARE com-
plexes in epididymal WAT lysates by measuring the amount of
VAMP-4 (vSNARE) that coimmunoprecipitated with syntaxin-5
(tSNARE). Although we found no differences between geno-
types for LFD-fed mice, the number of SNARE complexes was
reduced by ∼35% in γ-synuclein−/− mice fed HFD compared
with HFD-fed WT mice (Fig. 6 A and B). This difference was not
caused by reduced expression of VAMP-4, syntaxin-5, or SNAP-
23 in WAT of γ-synuclein−/− mice (Fig. S7 A and B).
To assess whether increasing γ-synuclein expression could af-
fect the number of SNARE complexes in cells, we infected un-
differentiated 3T3 cells, which do not express detectable level of
this protein, with control or γ-synuclein–expressing lentivirus. At
48 h after infection, assembled SNARE complexes were more
abundant in γ-synuclein–expressing cells than in control cells
(Fig. 6C).
In differentiating 3T3-L1 cells, we observed that γ-synuclein
and SNAP-23 colocalized within the cytoplasm (Fig. S7C).
However, acute treatment of cells with oleic acid to induce the
formation of lipid droplets led to partial loss of this colocaliza-
tion (Fig. S7 C and D). This is consistent with the hypothesis that
γ-synuclein interacts with a cytoplasmic form of SNAP-23 and
chaperones the assembly of SNARE complexes in conditions of
Fig. 4. γ-Synuclein affects lipolysis in mouse adipocytes. (A) Measurement
of lipolysis in adipocytes isolated from epididymal WAT of WT (+/+) and
γ-synuclein−/− (−/−) mice fed an HFD for 11 wk. Lipolysis was determined by
measuring glycerol released from adipocytes incubated for 2 h in the ab-
sence (basal) or presence (stim) of 10 μM isoproterenol (n = 8 animals per
group; *P < 0.05, **P < 0.01, Mann–Whitney U test). (B) Radioactive oleate
release was used to assess basal lipolysis in undifferentiated or differenti-
ated γ-synuclein−/− MEFs infected with lentiviruses encoding GFP or γ-syn-
uclein. Data are means ± SEM of [14C]oleate released during 4 h, expressed
as percentage of total incorporated [14C]oleate (***P < 0.001, Mann–
Whitney U test; n = 12). (C) Western blot analysis of protein expression
in epididymal WAT of WT and γ-synuclein−/− mice fed an LFD or HFD for
11 wk. GAPDH was used as a loading control.
Fig. 5. γ-Synuclein affects lipolysis in differentiated
3T3-L1 adipocytes. 3T3-L1 adipocytes were trans-
fected with control siRNA (Control-si) or siRNA tar-
geting γ-synuclein (γ-synuclein-si1 or γ-synuclein-si2).
(A) Cells were labeled for 16 h with [14C]oleate be-
fore incubation on day 8 of differentiation in the
absence (Basal) or presence of 1 nM or 1 μM iso-
proterenol as indicated for 30 min (Upper). Carbon
14 release as a proportion of total incorporated 14C
was determined. Results are means ± SEM compared
with identically treated cells transfected with con-
trol siRNA (*P < 0.05, Mann–Whitney U test; n = 5).
Identically transfected 3T3-L1 adipocyte cultures
were lysed, and the expression of γ-synuclein, aP2,
and calnexin was determined by Western blotting
(Lower). (B) Lipid droplet area in untreated cells was
determined as described in Methods, and shown as
means ± SEM. (C) At day 8 of differentiation, cells
were incubated for 30 min in the absence (Basal) or
presence of 1 μM isoproterenol before ﬁxing and
staining with antibody to endogenous ATGL (red),
Bodipy to reveal neutral lipid droplets (green), and
DAPI to visualize nuclei (blue). Individual grayscale
images are shown for ATGL and Bodipy as indicated.
White arrows highlight regions of ATGL interaction
with lipid droplets. (Scale bars: 20 μm; Insets, 5 μm.)
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increased lipid availability, despite not being a constituent of
these complexes itself.
Discussion
Our data show that γ-synuclein is an important regulator of adi-
pocyte function in vivo that can inﬂuence whole-body energy bal-
ance. KO of γ-synuclein, which is highly expressed in WAT, leads
to decreased weight gain inmice fed anHFD, and this is associated
with increased energy expenditure and lipid oxidation. Adipocytes
from γ-synuclein−/−mice exhibit increased basal and isoproterenol-
stimulated lipolysis whereas adipocyte size is decreased in vivo.
Together, this suggests that γ-synuclein loss promotes mobilization
of TG from adipocytes and increases lipid oxidation, most likely in
BAT, but potentially also in other tissues. In support of this hy-
pothesis, we observe increased basal and stimulated rates of lipol-
ysis in cultured adipocytes in which γ-synuclein has been knocked
down. This is associated with a signiﬁcant redistribution of ATGL
within the cell to lipid droplets similar to that observed in control
cells treated with isoproterenol to stimulate lipolysis. Our data
strongly argue that γ-synuclein acts as a cell-autonomous regulator
of lipolysis in adipocytes, particularly affecting ATGL function,
leading to decreased adipocyte size in γ-synuclein−/− mice.
It has previously been demonstrated that, in transgenic mice,
increased ATGL activity like γ-synuclein loss—speciﬁcally in
adipose tissue—leads to obesity resistance with increased energy
expenditure and lipid oxidation, decreased adipocyte size, and
reduced hepatic steatosis following HFD feeding, without af-
fecting food intake (16). Conversely, adipose-selective disruption
of ATGL leads to increased adiposity and a more WAT-like
phenotype in BAT (17). The lipolytic action of ATGL has been
shown to be important for inducing the expression of genes fa-
voring lipid oxidation genes in hepatocytes, macrophages, car-
diac muscle, and BAT, as well as increased thermogenesis in the
latter (17–20). As γ-synuclein is clearly detectable in BAT and
appears able to regulate ATGL function, activation of ATGL in
the BAT of γ-synuclein−/− mice may also increase lipolysis in this
tissue and drive the increased lipid oxidation proﬁle we observe.
The exact mechanism whereby γ-synuclein inﬂuences ATGL
localization and lipolysis, if this also occurs in brown adipocytes,
and whether this underlies the induction of genes controlling
lipid oxidation, are key questions we will seek to answer in our
future studies. However, the evidence from studies of ATGL
suggests that potentiating the lipolytic function of ATGL in
adipocytes could alone provide ample means via which the loss
of γ-synuclein could bring about the attenuated obesity and
metabolic phenotype we have observed.
Although γ-synuclein expression is particularly high in adipo-
cytes, we cannot completely exclude a role for γ-synuclein in
nonadipose tissues, primarily in the nervous system, that could
contribute to other aspects of the phenotype observed in mice
lacking this protein. However, we do show that speciﬁcally reex-
pressing γ-synuclein in the fat pads of null mutant mice reverses
the observed decrease in adipocyte size. Critically, this was seen in
only those adipocytes reexpressing γ-synuclein, and not in non-
transduced cells in the same depot. This, coupled to our data
showing that γ-synuclein knockdown in cultured adipocytes alters
lipid handling and lipid droplet size, strongly implies that this as-
pect of the in vivo phenotype is fat cell-autonomous.
It has been shown previously that γ-synuclein mRNA is a late
marker of adipocyte differentiation (8), and our data also suggest
that γ-synuclein does not play a major role in adipocyte differenti-
ation, indicating that the reduced adiposity of γ-synuclein−/− mice
does not reﬂect impaired capacity to expand adipose depots when
required. This is important, as human syndromes of lipodystrophy
and mouse models of restricted adipose expandability demonstrate
that merely constraining adipose mass leads to dyslipidemia, insulin
resistance, and metabolic disease (21, 22). As the loss of γ-synuclein
appears to selectively affectmature adipocytes, itmay prove a useful
therapeutic target for improving obesity-related metabolic disease.
It is also encouraging that no adverse phenotypes were apparent in
neuronal or other tissues, suggesting that altering γ-synuclein func-
tion therapeutically might not require tissue-selective targeting;
however, this clearly requires further conﬁrmation.
In addition to regulating lipolysis, we have also identiﬁed a fur-
ther, distinct function for γ-synuclein in adipocytes: regulating the
formation of SNARE complexes that are involved in lipid droplet
fusion, contributing to lipid accumulation in the adipocyte and
a consequent increase in its size (13–15). This provides an in-
triguing echo of the function of α-synuclein in neuronal synapses,
where it enhances neurotransmitter exocytosis by promoting the
assembly of SNARE complexes, with a pivotal role in synaptic
vesicle docking and fusion pore formation at the plasma mem-
brane (11). Hence, our data imply that, in very different cellular
systems, α-synuclein and γ-synuclein share a fundamental func-
tion, namely potentiating SNARE-mediated fusion selectively
Fig. 6. Quantiﬁcation of SNARE complexes in adipocytes. (A) Representative
Western blots showing coimmunoprecipitation of VAMP-4 with syntaxin-5
used to assess SNARE complex abundance. Analysis of samples from epidid-
ymalWAT ofWT (+/+) and γ-synuclein−/− (−/−) mice fed an LFD or HFD for 11wk
is presented. (B) Quantiﬁcation of VAMP-4 in syntaxin-5 immunoprecipitates
normalized to the amount of immunoprecipitated syntaxin-5,expressed as
a percentage of WT samples in each experiment (±SEM, total of ﬁve in-
dependent experiments). (C) Quantiﬁcation of similar analysis of SNARE
complexes in 3T3-L1 cells 48 h after infection with lentiviruses expressing GFP
or γ-synuclein. Data are percentages of control from a mean of three in-
dependent experiments. (In B and C, *P < 0.05, Mann–Whitney U test.)
Fig. 7. Scheme of proposed role of γ-synuclein in lipid metabolism in WAT
adipocytes. In WT adipocytes, γ-synuclein promotes efﬁcient delivery of
SNAP-23 to the SNARE complex as it forms. Nutrient excess in vivo, or lipid
loading in culture, increases delivery of SNAP-23 to the SNARE complexes,
thereby decreasing the association of SNAP-23 with γ-synuclein. These
SNARE complexes facilitate the fusion of lipid droplets (LD) containing TG
generated from the esteriﬁcation of nonesteriﬁed fatty acids (NEFA), fa-
voring TG storage. In the absence of lipolytic stimulation, γ-synuclein also
retains the adipose TG lipase, ATGL, in a cytosolic location, possibly via
protein–protein interaction. In adipocytes lacking γ-synuclein, SNARE com-
plex formation, droplet fusion and thus TG accumulation is reduced. Loss of
γ-synuclein also leads to a redistribution of ATGL to the lipid droplet, in-
creasing basal lipolysis and priming the lipolytic machinery for hormonal
stimulation of lipolysis.
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under physiological and/or environmental conditions that require
this process to occur with increased efﬁciency.
We have demonstrated that, in conditions of increased lipid
supply, i.e., in HFD-fed mice, the lack of γ-synuclein substantially
attenuates of SNARE complex assembly in adipocytes. We pro-
pose that γ-synuclein delivers SNAP-23 to the forming SNARE
complex, and that this delivery is increased at times of nutrient
excess and increased lipid droplet formation or enlargement.
Conversely, overexpression of γ-synuclein in preadipocytes in-
creases the abundance of SNARE complexes. It is therefore
plausible that the decreased SNARE complex formation seen in
γ-synuclein–deﬁcient adipocytes reduces TAG incorporation into
the lipid droplet. Ultimately, this involves γ-synuclein in two key,
independent aspects of adipocyte biology regulating lipid droplet
formation and TG lipolysis (Fig. 7). Hence, these twin roles for
γ-synuclein may act in a concerted manner, converging to regulate
the size of lipid droplets and thereby adipocytes.
In conclusion, our study reveals an important role of γ-synu-
clein in adipocyte lipid metabolism and suggests that increased
γ-synuclein expression could contribute to the development of
obesity-related metabolic disease. In addition, inhibiting γ-syn-
uclein expression or function may represent a novel potential
therapeutic avenue for the treatment of this prevalent condition.
Methods
Animals. Production, genotyping, and initial characterization of γ-synuclein–
null mutant mice on a C57Bl6J genetic background have been described
previously (4). The colony was maintained by backcross breeding, and
intercrosses were used for production of experimental cohorts (details pro-
vided in SI Methods). From the age of 9 wk, animals were fed a 10% energy-
from-fat LFD or a 45% energy-from-fat HFD (23). Body mass changes and
food consumption were measured weekly. All animal work was carried out
in accordance with the UK Animals (Scientiﬁc Procedures) Act (1986) and
approved by the Ethical Review Committee of Cardiff University.
Metabolic Analysis.Metabolic rate inWT and γ-synuclein−/−mice in the eighth
week of HFD feeding was measured by indirect calorimetry with the use of
a CLAMS (Columbus Instruments). RER (volume of CO2/volume of O2) and
energy expenditure [using constants according to a previous publication
(24)] was determined over a 72-h period.
Isolation of Cells from WAT and Adipocyte Lipolysis. Mature adipocytes and
the preadipocyte-containing stromal cell fraction were isolated from epi-
didymal fat depots as described previously (25). Mature WAT adipocyte li-
polysis was quantiﬁed by glycerol release under basal [i.e., 200 nM (R)-(-)-N6-
(2-phenylisopropyl)adenosine] and catecholamine-stimulated [i.e., 200 nM
(R)-(-)-N6-(2-phenylisopropyl)adenosine plus 10 μM isoproterenol] conditions.
In 3T3-L1 adipocytes and MEFs, lipolysis was determined by 14C release from
cells loaded overnight with [14C]oleate, serum-deprived for 2 h, then stimu-
lated for 30 min with or without 1 nM or 1 μM isoproterenol as indicated,
essentially as described previously (26).
Expression Analysis. Levels of RNA were measured by using quantitative RT-
PCR and proteins by quantitative Western blotting as described previously
(27). Oligonucleotide primers, primary antibodies and dilutions used are
shown in SI Methods.
In Vitro Cell Culture Experiments. Primary cultures of MEFs from embryonic
day 12.5 embryos weremaintained and differentiated essentially as described
previously (28). 3T3-L1 cells were cultured, transfected, and differentiated as
previously described (29). Cells were transfected by siRNA at days 3 and 6 of
differentiation by using Lipofectamine RNA iMAX transfection reagent
(Invitrogen). Lipid droplet areas were calculated by using Volocity 6.1 (Per-
kin-Elmer). Analysis was performed on >2,400 droplets in randomly selected
ﬁelds. For reexpression studies, lentiviruses were added to cells for 48 h (106
virus transducing units per milliliter of medium). Additional methods are
described in SI Methods.
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